Best Fisetin Supplements in 2026: Senolytic Therapy Explained

Fisetin is a flavonoid found in strawberries, apples, and onions — and one of the most exciting compounds in modern longevity research. In 2018, Mayo Clinic researchers screening flavonoids for senolytic activity found fisetin to be the most potent of all — more powerful than quercetin, which had been the leading candidate.

Senolytics are a class of compounds that selectively destroy senescent cells — so-called "zombie cells" that accumulate with age, secrete inflammatory molecules, and drive tissue dysfunction. Clearing senescent cells in mice extends median lifespan by up to 25% and reverses many age-related declines. Human trials are ongoing, but the mouse data is compelling enough that many longevity-focused clinicians now recommend periodic senolytic protocols.

What are senescent cells (and why do they matter)?

Senescent cells are cells that have stopped dividing but refuse to die. They accumulate throughout life as a result of DNA damage, oxidative stress, telomere shortening, and other cellular stresses. Young immune systems clear them efficiently. With age, clearance slows and senescent cells build up.

The problem isn't just that these cells take up space — they secrete a toxic mix of inflammatory cytokines, proteases, and growth factors called the SASP (senescence-associated secretory phenotype). The SASP drives chronic low-grade inflammation ("inflammaging"), damages neighboring cells, and accelerates tissue aging.

Mouse studies show that transplanting senescent cells into young mice accelerates aging — and clearing senes cells from old mice reverses many age-related declines. This is the case for senolytic therapy: selectively kill senescent cells to remove the source of inflammaging.

Mayo Clinic research on fisetin

In a landmark 2018 paper published in EBioMedicine, Mayo Clinic researchers screened 10 flavonoids for senolytic activity. Fisetin emerged as the most potent — effectively killing senescent cells at low concentrations while sparing healthy cells. The same paper showed fisetin administration extended median lifespan in aged mice by roughly 10%.

Subsequent research has shown fisetin reduces senescent cell burden in human adipose tissue (ex vivo), and early human clinical trials are underway. The SToMP-TIME trial at Mayo Clinic is testing fisetin in older adults with frailty; results are expected in 2025–2026.

It's important to be honest about the evidence: fisetin is a leading senolytic candidate, but most human data is still emerging. The mouse evidence is strong; the human translation is in progress. We treat fisetin as an experimental-but-promising longevity intervention, not a proven therapy.

Hit-and-run dosing: why intermittent?

Senolytics are dosed intermittently — typically 2–3 consecutive days per month — for a specific reason. Senescent cells are a finite population. A pulsed dose clears the existing pool; then you wait for new senescent cells to accumulate before repeating the clearance. Continuous daily dosing isn't necessary and may even cause off-target effects.

This "hit-and-run" protocol was pioneered by Mayo Clinic researchers and is now the standard in senolytic clinical trials. Continuous low-dose senolytic therapy doesn't make biological sense — you want a high enough concentration to trigger apoptosis in senescent cells, then remove the drug.

The 500mg x 2 days/month protocol

The most commonly cited fisetin protocol in longevity circles is 500mg per day for 2 consecutive days, repeated monthly. This is loosely based on the equivalent mouse dosing that produced lifespan extension and is what's being tested in current human trials.

Some practitioners use higher doses (1000–1500mg per day for 2–3 days) or extend the protocol to 3 consecutive days. There's no consensus yet on the optimal human dose. We recommend starting with the conservative 500mg x 2 days/month protocol and adjusting based on tolerance.

Fisetin is fat-soluble, so take it with a fat-containing meal to improve absorption. Some practitioners also recommend taking fisetin with quercetin (another senolytic) for additive effects.

Fisetin vs quercetin — and combining them

Quercetin is another senolytic flavonoid, often paired with the chemotherapy drug dasatinib in Mayo Clinic trials. The dasatinib + quercetin combo was the original senolytic protocol; fisetin has emerged as a more potent (and more accessible) alternative.

Some practitioners combine fisetin and quercetin for additive senolytic effects. The rationale: the two compounds may target different senescent cell populations (dasatinib targets senescent fat cells; quercetin targets senescent endothelial cells; fisetin appears broad-spectrum). Stacking may give broader coverage.

See our quercetin guide for more on quercetin dosing and synergy. Our supplement stack guide shows how fisetin fits into a complete longevity protocol alongside NAD+ boosters like NMN and mTOR modulators like spermidine.

Our top pick: HUMANX Fisetin 500mg

HUMANX Fisetin delivers 500mg of fisetin per capsule — exactly the dose used in the popular monthly senolytic protocol. One capsule per day for 2 consecutive days, repeated monthly, matches the most-cited longevity protocol.

HUMANX uses 98%+ pure fisetin extract (verified by third-party testing), which matters because lower-purity fisetin supplements contain significant amounts of inactive fillers. The 60-capsule bottle provides a year's supply at the monthly protocol dose.

HUMANX is a newer brand focused specifically on longevity compounds — their fisetin is one of the few products on the market dosed appropriately for senolytic use. Most mainstream fisetin supplements are dosed at 100–200mg, which is far too low for senolytic effects.

How to take fisetin

1. Dose: 500mg per day for 2 consecutive days, repeated monthly. (One HUMANX capsule per day.)
2. Take with fat: Fisetin is fat-soluble. Take with a fat-containing meal to improve absorption.
3. Mark your calendar: Pick 2 consecutive days each month (e.g., the 1st and 2nd) and stick to them. Consistency matters more than the specific dates.
4. Consider combining with quercetin: Some practitioners add 500mg quercetin on the same 2 days for additive senolytic effects.
5. Talk to your doctor if on medications: Fisetin may interact with medications metabolized by CYP enzymes. Check with your physician if you take prescription drugs.

The bottom line

Fisetin is the most potent senolytic flavonoid identified to date, with strong mouse evidence for lifespan extension and ongoing human trials. The standard protocol is 500mg per day for 2 consecutive days, repeated monthly — a "hit-and-run" approach that clears senescent cells while they're a finite, targetable population.

Our recommendation: HUMANX Fisetin 500mg. It's dosed correctly for senolytic use, third-party tested for purity, and provides a year's supply per bottle. Most competing fisetin products are dosed too low for senolytic effects.

Be realistic about the evidence: fisetin is promising but not yet proven in humans. We treat it as an experimental-but-reasonable addition to a longevity protocol — particularly for older adults (50+) where senescent cell burden is higher. Combine with foundational interventions like NMN, spermidine, and resveratrol for a comprehensive longevity stack. For more on the science, see our guide to lowering biological age.